Romain Arrestier - Concepedia

Author

Romain Arrestier

Also Known As

Abdelkader Azza, Armand Mekontso Dessap, Astrid Bertier, Keyvan Razazi, Marianne Ziol, Marie-Alexandra Alyanakian, Miquel Alfonso Ramos, R. Arrestier, Romain ARRESTIER, Romain Arrestier

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Inserm Assistance Publique – Hôpitaux de Paris Hôpitaux Universitaires Henri-Mondor Université Paris-Est Créteil Sorbonne Université

About

Romain Arrestier is an author at Inserm specializing in covid-19, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	276
2	Immunology	2	2	263
3	Epidemiology	1	1	180
4	Pulmonary Disease	1	1	13
5	Pulmonary Medicine	1	1	13

Romain Arrestier

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Paul Bastard, Adrian Gervais, Tom Le Voyer, Science Immunology	2021	600
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies Jérémy Manry, Paul Bastard, Adrian Gervais, Proceedings of the National Academy of Sciences Ifn AutoantibodiesImmunologyAge DependentCovid-19Disease Susceptibility	2022	180
Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease Keyvan Razazi, Romain Arrestier, Anne Fleur Haudebourg, Critical Care	2020	145
The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury and/or proteinuria Sophie Ferlicot, Matthieu Jamme, F. Gaillard, Nephrology Dialysis Transplantation	2021	88
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia Nicolas de Prost, Paul Bastard, Romain Arrestier, Journal of Clinical Immunology Autoimmune DiseaseCovid-19 PandemicImmunologyAntiviral ResponseAutoimmunity	2021	83
Correction to: Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease Keyvan Razazi, Romain Arrestier, Anne Fleur Haudebourg, Critical Care	2021	71
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study Romain Arrestier, Paul Bastard, Thibaut Belmondo, Annals of Intensive Care	2022	34
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies Jérémy Manry, Paul Bastard, Adrian Gervais,	2022	24
Risks Of Ventilator-Associated Pneumonia And Invasive Pulmonary Aspergillosis In Patients With Viral Acute Respiratory Distress Syndrome Related or Not To Coronavirus 19 Disease Keyvan Razazi, Romain Arrestier, Anne-Fleur Haudebourg, Acute Lung InjuryVap EpisodeRespiratory Distress Syndrome (Pulmonary Critical Care)Respiratory DiseasesInvasive Pulmonary Aspergillosis	2020	13
Performance and impact of rapid multiplex PCR on diagnosis and treatment of ventilated hospital-acquired pneumonia in patients with extended-spectrum β-lactamase-producing Enterobacterales rectal carriage Pierre Bay, Vincent Fihman, Paul‐Louis Woerther, Annals of Intensive Care	2024	12

Page 1